Redeterminations, which began earlier this month, are not expected to result in a “significant margin impact,” Molina’s CEO said, as the payer raised its full-year guidance.
Redeterminations, which began earlier this month, are not expected to result in a “significant margin impact,” Molina’s CEO said, as the payer raised its full-year guidance.